Singapore: A Myriad of Biotech Financing Strategies

Histoindex – A Much Improved Ecosystem

Precision diagnostics firm Histoindex began life as a spinoff from A*STAR and so received funding from the Singaporean government as well as from angel investors, corporations, and institutions. Co-founder and CEO, Dr. Gideon Ho, highlights Singapore’s advantages for innovative start-up firms looking to grow in Singapore.

Click here to read the excerpt on HistoIndex in the full article, Singapore: A Myriad of Biotech Financing Strategies on PharmaBoardroom.